Richard Fair
Director/Board Member at BELLICUM PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David O. Beim | M | 84 |
Columbia Business School
| 33 years |
| James Johnson Duderstadt | M | 80 |
University of Michigan
| 36 years |
| Jeoffrey K. Stross | M | 82 |
University of Michigan
| 37 years |
| Ehud Houminer | M | 83 |
Columbia Business School
| 33 years |
| Murray Low | M | 71 |
Columbia Business School
| 34 years |
| Jun Ni | M | 61 |
University of Michigan
| 37 years |
| Dave Maggio | M | 64 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin M. Slawin | M | 63 | 13 years | |
| Alan Musso | M | 62 | 4 years | |
| Patrick Mahaffy | M | 61 | 14 years | |
| Corazon Sanders | M | 67 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Corwin Dale Hooks | M | 56 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 14 years |
| Michael Barrett | M | 81 | 10 years | |
| Ginger Graham | F | 68 | 10 years | |
| Paul Gross | M | 59 | 7 years | |
| Louis Lavigne | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Jon Stonehouse | M | 63 | 10 years | |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Pascal Soriot | M | 64 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Thomas J. Farrell | M | 60 | 11 years | |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
| Keith Flaherty | M | 53 | 10 years | |
| William Grossman | M | 54 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 4 years |
| Alexander Hardy | M | 56 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Edmund Harrigan | M | 71 | 1 years | |
| Bahadir Inozu | M | - |
University of Michigan
| 5 years |
| Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Sandra Horning | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Katherine A. Lauer | F | - |
University of Michigan
| 7 years |
| Reid Huber | M | 52 | 10 years | |
| Jakob Dupont | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| David M. di Rita | M | - |
University of Michigan
| 7 years |
| Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Haluk Dinçer | M | 62 |
University of Michigan
| 6 years |
| James Daly | M | 62 | 8 years | |
| Shane Ward | M | 49 | 2 years | |
| Joseph Howard Senesac | M | - | 12 years | |
| Jung-Sik Koh | M | - |
University of Michigan
| - |
| Wissam Jabre | M | 54 |
Columbia Business School
| 6 years |
| Robert Fogler | M | - |
University of Michigan
| 8 years |
| Kok Siong Yun | M | 54 |
University of Michigan
| 5 years |
| Alex Horvitz | M | - |
University of Michigan
| 5 years |
| Lawrence Wieser | M | - |
University of Michigan
| 6 years |
| Gísli S. Óttarsson | M | - |
University of Michigan
| 6 years |
| June Lee | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Lori Wheeler-Naess | F | 53 |
University of Michigan
| 5 years |
| Robert Azelby | M | 56 | 5 years | |
| Scott Smith | M | - |
University of Michigan
| 5 years |
| Lindsey Rolfe | M | 56 | 13 years | |
| Asha Das | M | 59 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Ryan Watts | M | 48 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Michelle Epstein Taigman | F | 55 |
University of Michigan
| 7 years |
| Gerald I. Wilson | M | - |
University of Michigan
| 3 years |
| James Farrell Brown | M | 59 | 11 years | |
| D. Nordlund | M | - |
University of Michigan
| 3 years |
| Dong-Yeon Kim | M | - |
University of Michigan
| 3 years |
| Annemarie B. Moseley | M | 68 | 6 years | |
| Gil Syswerda | M | - |
University of Michigan
| 5 years |
| Breanna Burkart | F | - | 14 years | |
| Brian Atwood | M | 71 | 14 years | |
| Roy Liu | M | 63 |
University of Michigan
| 10 years |
| Thorlef Spickschen | M | 83 | 14 years | |
| Andrew B. Bressler | M | - |
University of Michigan
| 5 years |
| Mitch A. Mondry | M | - |
University of Michigan
| 8 years |
| Jeffrey Allen Wrona | M | - |
University of Michigan
| 7 years |
| Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Stephen Davis | M | 63 | 9 years | |
| Paul Klingenstein | M | 68 | 14 years | |
| John Pinion | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| James Blair | M | 84 | 14 years | |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Stephen G. Juelsgaard | M | 75 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Edward McKinley | M | 72 | 14 years | |
| Daniel Muehl | M | 61 | 8 years | |
| Daniel Hamburger | M | 60 |
University of Michigan
| 5 years |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
| Bruce R. Hill | M | - |
University of Michigan
| 6 years |
| Frank B. McGuyer | M | 72 | 9 years | |
| Michael Varney | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| David M. Kortenkamp | M | - |
University of Michigan
| 4 years |
| Robert Garnick | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Guru Kothandaraman | M | - |
University of Michigan
| 5 years |
| Mohammad Al-Ramadham | M | - |
University of Michigan
| 4 years |
| William Anderson | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Tracey C. Robinson | F | - |
University of Michigan
| 7 years |
| David M. Spencer | M | 61 | 15 years | |
| Ronit Simantov | M | 59 | 2 years | |
| John F. C. Cheong | M | - |
University of Michigan
| 5 years |
| Alan K. Smith | M | 68 | 5 years | |
| Michael S. Russell | M | - |
University of Michigan
| 7 years |
| Douglass M. Rayburn | M | - |
University of Michigan
| 3 years |
| Bruce Cameron Greig | M | - |
University of Michigan
| 9 years |
| Smith Jordan | M | - |
University of Michigan
| 7 years |
| Michelle Bryan Oroschakoff | F | 62 |
University of Michigan
| 3 years |
| Andrew William Kahn | M | - |
University of Michigan
| 4 years |
| Robin Foley | F | - |
University of Michigan
| 4 years |
| Scott LaBarge | M | - |
University of Michigan
| 4 years |
| James Lico | M | 58 |
University of Michigan
| 4 years |
| Aaron Rappaport | M | - |
University of Michigan
| 3 years |
| Daniel L. Goldberg | M | - |
University of Michigan
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Fair
- Personal Network
